Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Aleksandar Videnovic, M.D.

Title
Institution
Department
Address
Phone
Profile Picture

Biography
University of Belgrade, BelgradeMD12/1994Medicine
Northwestern University, Chicago06/2005Neurology
Rush University, Chicago06/2007Movement Disorders
Rush University , ChicagoMS06/2007Clinical Research / Clinical Trials
Northwestern University , Chicago06/2008Sleep Medicine

Overview

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. PPMI 2.0 Dec 1, 2020 - Nov 30, 2025
    Michael J Fox Foundation for Parkinson's Research
    The Parkinson’s Progression Markers Initiative (PPMI) 2.0 Clinical - Establishing a Deeply Phenotyped PD Cohort
    Role: Site Principal Investigator
  2. R01AG063982 (BIANCIARDI, MARTA) May 15, 2020 - Apr 30, 2025
    NIH
    Brainstem-based imaging biomarkers of premanifest synucleinopathy
    Role: Co-Investigator
  3. U01NS114001 (VIDENOVIC, ALEKSANDAR) Sep 15, 2019 - Jun 30, 2022
    NIH
    A Dose Selection Trial of Light Therapy for Impaired Sleep in Parkinson's Disease
    Role: Principal Investigator
  4. R21NS108022 (VIDENOVIC, ALEKSANDAR) Jul 15, 2018 - Jun 30, 2021
    NIH
    Circadian Rhythms Regulation in Pre-Manifest Synucleinopathies
    Role: Principal Investigator
  5. R34AG056639 (JU, YO-EL S) May 1, 2018 - Apr 30, 2020
    NIH
    Neuroprotective Treatment Trial Planning in REM Sleep Behavior Disorder
    Role: Co-Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, Scott B, Gauger L, Aldred J, Bixby M, Ciccarello J, Gunzler SA, Henchcliffe C, Brodsky M, Keith K, Hauser RA, Goetz C, LeDoux MS, Hinson V, Kumar R, Espay AJ, Jimenez-Shahed J, Hunter C, Christine C, Daley A, Leehey M, de Marcaida JA, Friedman JH, Hung A, Bwala G, Litvan I, Simon DK, Simuni T, Poon C, Schiess MC, Chou K, Park A, Bhatti D, Peterson C, Criswell SR, Rosenthal L, Durphy J, Shill HA, Mehta SH, Ahmed A, Deik AF, Fang JY, Stover N, Zhang L, Dewey RB, Gerald A, Boyd JT, Houston E, Suski V, Mosovsky S, Cloud L, Shah BB, Saint-Hilaire M, James R, Zauber SE, Reich S, Shprecher D, Pahwa R, Langhammer A, LaFaver K, LeWitt PA, Kaminski P, Goudreau J, Russell D, Houghton DJ, Laroche A, Thomas K, McGraw M, Mari Z, Serrano C, Blindauer K, Rabin M, Kurlan R, Morgan JC, Soileau M, Ainslie M, Bodis-Wollner I, Schneider RB, Waters C, Ratel AS, Beck CA, Bolger P, Callahan KF, Crotty GF, Klements D, Kostrzebski M, McMahon GM, Pothier L, Waikar SS, Lang A, Mestre T. Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. JAMA. 2021 09 14; 326(10):926-939. PMID: 34519802.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  2. Videnovic A, Amara AW, Comella C, Schweitzer PK, Emsellem H, Liu K, Sterkel AL, Gottwald MD, Steinerman JR, Jochelson P, Zomorodi K, Hauser RA. Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial. Mov Disord. 2021 10; 36(10):2408-2412. PMID: 34191352.
    Citations:    Fields:    
  3. Thakur N, Klopstock T, Jackowski S, Kuscer E, Tricta F, Videnovic A, Jinnah HA. Rational Design of Novel Therapies for Pantothenate Kinase-Associated Neurodegeneration. Mov Disord. 2021 09; 36(9):2005-2016. PMID: 34002881.
    Citations: 1     Fields:    
  4. Gossard TR, Trotti LM, Videnovic A, St Louis EK. Restless Legs Syndrome: Contemporary Diagnosis and Treatment. Neurotherapeutics. 2021 01; 18(1):140-155. PMID: 33880737.
    Citations: 1     Fields:    
  5. Steele TA, St Louis EK, Videnovic A, Auger RR. Circadian Rhythm Sleep-Wake Disorders: a Contemporary Review of Neurobiology, Treatment, and Dysregulation in Neurodegenerative Disease. Neurotherapeutics. 2021 01; 18(1):53-74. PMID: 33844152.
    Citations: 3     Fields:    
  6. St Louis EK, Videnovic A. Sleep Neurology's Toolkit at the Crossroads: Challenges and Opportunities in Neurotherapeutics Lost and Found in Translation. Neurotherapeutics. 2021 01; 18(1):1-5. PMID: 33821447.
    Citations:    Fields:    
  7. Fifel K, Videnovic A. Circadian and Sleep Dysfunctions in Neurodegenerative Disorders-An Update. Front Neurosci. 2020; 14:627330. PMID: 33536872.
    Citations: 2     
  8. Amundsen-Huffmaster SL, Petrucci MN, Linn-Evans ME, Chung JW, Howell MJ, Videnovic A, Tuite PJ, Cooper SE, MacKinnon CD. REM Sleep Without Atonia and Gait Impairment in People with Mild-to-Moderate Parkinson's Disease. J Parkinsons Dis. 2021; 11(2):767-778. PMID: 33523016.
    Citations:    Fields:    
  9. St Louis EK, Videnovic A. Correction to: Sleep Neurology's Toolkit at the Crossroads: Challenges and Opportunities in Neurotherapeutics Lost and Found in Translation. Neurotherapeutics. 2021 Jan; 18(1):656. PMID: 33939132.
    Citations:    Fields:    
  10. Teigen LN, Sharp RR, Hirsch JR, Campbell E, Timm PC, Sandness DJ, Feemster JC, Gossard TR, Faber SM, Steele TA, Rivera S, Junna MR, Lipford MC, Tippmann-Peikert M, Kotagal S, Ju YE, Howell M, Schenck CH, Videnovic A, Jennum P, Hogl B, Stefani A, Arnulf I, Heidbreder A, Lewis S, McCarter SJ, Boeve BF, Silber MH, St Louis EK. Specialist approaches to prognostic counseling in isolated REM sleep behavior disorder. Sleep Med. 2021 03; 79:107-112. PMID: 33486257.
    Citations: 1     Fields:    Translation:Humans
  11. Chahine LM, Brumm MC, Caspell-Garcia C, Oertel W, Mollenhauer B, Amara A, Fernandez-Arcos A, Tolosa E, Simonet C, Hogl B, Videnovic A, Hutten SJ, Tanner C, Weintraub D, Burghardt E, Coffey C, Cho HR, Kieburtz K, Poston KL, Merchant K, Galasko D, Foroud T, Siderowf A, Marek K, Simuni T, Iranzo A. Dopamine transporter imaging predicts clinically-defined a-synucleinopathy in REM sleep behavior disorder. Ann Clin Transl Neurol. 2021 01; 8(1):201-212. PMID: 33321002.
    Citations:    Fields:    Translation:Humans
  12. Klopstock T, Videnovic A, Bischoff AT, Bonnet C, Cif L, Comella C, Correa-Vela M, Escolar ML, Fraser JL, Gonzalez V, Hermanowicz N, Jech R, Jinnah HA, Kmiec T, Lang A, Martí MJ, Mercimek-Andrews S, Monduy M, Nimmo GAM, Perez-Dueñas B, Pfeiffer HCV, Planellas L, Roze E, Thakur N, Tochen L, Vanegas-Arroyave N, Zorzi G, Burns C, Greblikas F. Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase-Associated Neurodegeneration. Mov Disord. 2021 06; 36(6):1342-1352. PMID: 33200489.
    Citations: 3     Fields:    Translation:Humans
  13. Fifel K, Videnovic A. Circadian alterations in patients with neurodegenerative diseases: Neuropathological basis of underlying network mechanisms. Neurobiol Dis. 2020 10; 144:105029. PMID: 32736083.
    Citations: 3     Fields:    Translation:Humans
  14. Huh YE, Chiang MSR, Locascio JJ, Liao Z, Liu G, Choudhury K, Kuras YI, Tuncali I, Videnovic A, Hunt AL, Schwarzschild MA, Hung AY, Herrington TM, Hayes MT, Hyman BT, Wills AM, Gomperts SN, Growdon JH, Sardi SP, Scherzer CR. ß-Glucocerebrosidase activity in GBA-linked Parkinson disease: The type of mutation matters. Neurology. 2020 08 11; 95(6):e685-e696. PMID: 32540937.
    Citations: 5     Fields:    Translation:Humans
  15. Videnovic A, Ju YS, Arnulf I, Cochen-De Cock V, Högl B, Kunz D, Provini F, Ratti PL, Schiess MC, Schenck CH, Trenkwalder C. Clinical trials in REM sleep behavioural disorder: challenges and opportunities. J Neurol Neurosurg Psychiatry. 2020 07; 91(7):740-749. PMID: 32404379.
    Citations: 3     Fields:    Translation:Humans
  16. Linn-Evans ME, Petrucci MN, Amundsen Huffmaster SL, Chung JW, Tuite PJ, Howell MJ, Videnovic A, MacKinnon CD. REM sleep without atonia is associated with increased rigidity in patients with mild to moderate Parkinson's disease. Clin Neurophysiol. 2020 08; 131(8):2008-2016. PMID: 32451296.
    Citations: 6     Fields:    Translation:Humans
  17. Mateen FJ, Vogel AC, Kaplan TB, Hotan GC, Grundy SJ, Holroyd KB, Manalo N, Stauder M, Videnovic A. Light therapy for multiple sclerosis-associated fatigue: a randomized, controlled phase II trial. J Neurol. 2020 Aug; 267(8):2319-2327. PMID: 32333168.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  18. Stefani A, Ferini-Strambi L, Postuma RB, Iranzo A, Videnovic A, Högl B, Wenning GK. Olfaction in patients with isolated REM sleep behavior disorder who eventually develop multiple system atrophy. Sleep. 2020 04 15; 43(4). PMID: 31919509.
    Citations: 1     Fields:    
  19. Srikanth P, Al-Louzi OA, Bowley MP, Videnovic A. A Novel XK Gene Mutation Causative of McLeod Syndrome. Mov Disord Clin Pract. 2020 Apr; 7(3):340-342. PMID: 32258238.
    Citations:    
  20. Gros P, Videnovic A. Overview of Sleep and Circadian Rhythm Disorders in Parkinson Disease. Clin Geriatr Med. 2020 02; 36(1):119-130. PMID: 31733692.
    Citations: 2     Fields:    Translation:Humans
  21. Marshall RD, Collins A, Escolar ML, Jinnah HA, Klopstock T, Kruer MC, Videnovic A, Robichaux-Viehoever A, Burns C, Swett LL, Revicki DA, Bender RH, Lenderking WR. Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration. Orphanet J Rare Dis. 2019 07 12; 14(1):174. PMID: 31300018.
    Citations: 3     Fields:    Translation:Humans
  22. Oyegbile T, Videnovic A. Irregular Sleep-Wake Rhythm Disorder. Neurol Clin. 2019 08; 37(3):553-561. PMID: 31256789.
    Citations:    Fields:    Translation:Humans
  23. Klopstock T, Escolar ML, Marshall RD, Perez-Dueñas B, Tuller S, Videnovic A, Greblikas F. The FOsmetpantotenate Replacement Therapy (FORT) randomized, double-blind, Placebo-controlled pivotal trial: Study design and development methodology of a novel primary efficacy outcome in patients with pantothenate kinase-associated neurodegeneration. Clin Trials. 2019 08; 16(4):410-418. PMID: 31055958.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  24. Stefani A, Iranzo A, Sixel-Döring F, Videnovic A, Santamaria J, Trenkwalder C, Högl B. Need for a consensus on definitions and on research methods in RBD and its prodromal phases. Sleep. 2019 05 01; 42(5). PMID: 31091537.
    Citations:    Fields:    Translation:Humans
  25. Baca CM, Benish S, Videnovic A, Lundgren K, Magliocco B, Schierman B, Palmer L, Jones LK. Axon Registry® data validation: Accuracy assessment of data extraction and measure specification. Neurology. 2019 04 30; 92(18):847-858. PMID: 30952797.
    Citations: 1     Fields:    Translation:Humans
  26. Postuma RB, Iranzo A, Hu M, Högl B, Boeve BF, Manni R, Oertel WH, Arnulf I, Ferini-Strambi L, Puligheddu M, Antelmi E, Cochen De Cock V, Arnaldi D, Mollenhauer B, Videnovic A, Sonka K, Jung KY, Kunz D, Dauvilliers Y, Provini F, Lewis SJ, Buskova J, Pavlova M, Heidbreder A, Montplaisir JY, Santamaria J, Barber TR, Stefani A, St Louis EK, Terzaghi M, Janzen A, Leu-Semenescu S, Plazzi G, Nobili F, Sixel-Doering F, Dusek P, Bes F, Cortelli P, Ehgoetz Martens K, Gagnon JF, Gaig C, Zucconi M, Trenkwalder C, Gan-Or Z, Lo C, Rolinski M, Mahlknecht P, Holzknecht E, Boeve AR, Teigen LN, Toscano G, Mayer G, Morbelli S, Dawson B, Pelletier A. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain. 2019 03 01; 142(3):744-759. PMID: 30789229.
    Citations: 98     Fields:    Translation:HumansCTClinical Trials
  27. Videnovic A, Messinis L. Enlightened PD: A novel treatment for Parkinson disease? Neurology. 2019 03 12; 92(11):499-500. PMID: 30770427.
    Citations: 1     Fields:    Translation:Humans
  28. Chahine LM, Iranzo A, Fernández-Arcos A, Simuni T, Seedorff N, Caspell-Garcia C, Amara AW, Comella C, Högl B, Hamilton J, Marek K, Mayer G, Mollenhauer B, Postuma R, Tolosa E, Trenkwalder C, Videnovic A, Oertel W. Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder. NPJ Parkinsons Dis. 2019; 5:2. PMID: 30701189.
    Citations: 8     
  29. Marshall RD, Collins A, Escolar ML, Jinnah HA, Klopstock T, Kruer MC, Videnovic A, Robichaux-Viehoever A, Swett L, Revicki DA, Bender RH, Lenderking WR. A Scale to Assess Activities of Daily Living in Pantothenate Kinase-Associated Neurodegeneration. Mov Disord Clin Pract. 2019 Feb; 6(2):139-149. PMID: 30838313.
    Citations: 5     
  30. Fifel K, Videnovic A. Chronotherapies for Parkinson's disease. Prog Neurobiol. 2019 03; 174:16-27. PMID: 30658126.
    Citations: 5     Fields:    Translation:Humans
  31. Stefani A, Heidbreder A, Brandauer E, Guaita M, Neier LM, Mitterling T, Santamaria J, Iranzo A, Videnovic A, Trenkwalder C, Sixel-Döring F, Wenning GK, Chade A, Poewe W, Gershanik OS, Högl B. Screening for idiopathic REM sleep behavior disorder: usefulness of actigraphy. Sleep. 2018 06 01; 41(6). PMID: 29554362.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  32. Videnovic A. Disturbances of Sleep and Alertness in Parkinson's Disease. Curr Neurol Neurosci Rep. 2018 04 19; 18(6):29. PMID: 29675716.
    Citations: 7     Fields:    Translation:Humans
  33. Fifel K, Videnovic A. Light Therapy in Parkinson's Disease: Towards Mechanism-Based Protocols. Trends Neurosci. 2018 05; 41(5):252-254. PMID: 29588060.
    Citations: 3     Fields:    Translation:HumansAnimals
  34. Bin-Hasan S, Videnovic A, Maski K. Nocturnal REM Sleep Without Atonia Is a Diagnostic Biomarker of Pediatric Narcolepsy. J Clin Sleep Med. 2018 02 15; 14(2):245-252. PMID: 29351827.
    Citations: 5     Fields:    Translation:Humans
  35. Högl B, Stefani A, Videnovic A. Idiopathic REM sleep behaviour disorder and neurodegeneration - an update. Nat Rev Neurol. 2018 01; 14(1):40-55. PMID: 29170501.
    Citations: 75     Fields:    Translation:Humans
  36. Videnovic A, Klerman EB, Zee PC. Light Therapy Promoting Dopamine Release by Stimulating Retina in Parkinson Disease-Reply. JAMA Neurol. 2017 10 01; 74(10):1268-1269. PMID: 28806434.
    Citations: 3     Fields:    Translation:Humans
  37. Mateen FJ, Manalo NC, Grundy SJ, Houghton MA, Hotan GC, Erickson H, Videnovic A. Light therapy for multiple sclerosis-associated fatigue: Study protocol for a randomized controlled trial. Medicine (Baltimore). 2017 Sep; 96(36):e8037. PMID: 28885372.
    Citations: 1     Fields:    Translation:Humans
  38. Ju YS, Videnovic A, Vaughn BV. Comorbid Sleep Disturbances in Neurologic Disorders. Continuum (Minneap Minn). 2017 08; 23(4, Sleep Neurology):1117-1131. PMID: 28777179.
    Citations: 5     Fields:    Translation:Humans
  39. Gros P, Videnovic A. SLEEP AND CIRCADIAN RHYTHM DISORDERS IN PARKINSON'S DISEASE. Curr Sleep Med Rep. 2017 Sep; 3(3):222-234. PMID: 29177129.
    Citations: 3     
  40. Amara AW, Chahine LM, Videnovic A. Treatment of Sleep Dysfunction in Parkinson's Disease. Curr Treat Options Neurol. 2017 Jul; 19(7):26. PMID: 28567500.
    Citations: 11     
  41. Amara AW, Chahine LM, Caspell-Garcia C, Long JD, Coffey C, Högl B, Videnovic A, Iranzo A, Mayer G, Foldvary-Schaefer N, Postuma R, Oertel W, Lasch S, Marek K, Simuni T. Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease. J Neurol Neurosurg Psychiatry. 2017 08; 88(8):653-662. PMID: 28554959.
    Citations: 14     Fields:    Translation:Humans
  42. Gibbons CH, Simon DK, Huang M, Tilley B, Aminoff MJ, Bainbridge JL, Brodsky M, Freeman R, Goudreau J, Hamill RW, Luo ST, Singer C, Videnovic A, Bodis-Wollner I, Wong PS. Autonomic and electrocardiographic findings in Parkinson's disease. Auton Neurosci. 2017 07; 205:93-98. PMID: 28506500.
    Citations: 3     Fields:    Translation:Humans
  43. Videnovic A, Klerman EB, Wang W, Marconi A, Kuhta T, Zee PC. Timed Light Therapy for Sleep and Daytime Sleepiness Associated With Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol. 2017 Apr 01; 74(4):411-418. PMID: 28241159.
    Citations: 45     Fields:    Translation:Humans
  44. Videnovic A. Management of sleep disorders in Parkinson's disease and multiple system atrophy. Mov Disord. 2017 05; 32(5):659-668. PMID: 28116784.
    Citations: 18     Fields:    Translation:Humans
  45. Musiek ES, Videnovic A. Sleep and clocks - implications for brain health. Neurobiol Sleep Circadian Rhythms. 2017 Jan; 2:1-3. PMID: 31236492.
    Citations:    
  46. Videnovic A, Golombek D. Circadian Dysregulation in Parkinson's Disease. Neurobiol Sleep Circadian Rhythms. 2017 Jan; 2:53-58. PMID: 28713867.
    Citations: 10     
  47. Chahine LM, Amara AW, Videnovic A. A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015. Sleep Med Rev. 2017 10; 35:33-50. PMID: 27863901.
    Citations: 60     Fields:    Translation:Humans
  48. Alibiglou L, Videnovic A, Planetta PJ, Vaillancourt DE, MacKinnon CD. Subliminal gait initiation deficits in rapid eye movement sleep behavior disorder: A harbinger of freezing of gait? Mov Disord. 2016 11; 31(11):1711-1719. PMID: 27250871.
    Citations: 14     Fields:    Translation:Humans
  49. Chahine LM, Xie SX, Simuni T, Tran B, Postuma R, Amara A, Oertel WH, Iranzo A, Scordia C, Fullard M, Linder C, Purri R, Darin A, Rennert L, Videnovic A, Del Riva P, Weintraub D. Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder. Parkinsonism Relat Disord. 2016 06; 27:102-6. PMID: 27010070.
    Citations: 39     Fields:    Translation:Humans
  50. Videnovic A, Willis GL. Circadian system - A novel diagnostic and therapeutic target in Parkinson's disease? Mov Disord. 2016 Mar; 31(3):260-9. PMID: 26826022.
    Citations: 22     Fields:    Translation:HumansAnimals
  51. Abbott SM, Videnovic A. Chronic sleep disturbance and neural injury: links to neurodegenerative disease. Nat Sci Sleep. 2016; 8:55-61. PMID: 26869817.
    Citations: 23     
  52. Hirata K, Högl B, Tan EK, Videnovic A. Sleep Problems in Parkinson's Disease. Parkinsons Dis. 2015; 2015:507948. PMID: 26788402.
    Citations: 1     
  53. Videnovic A, Zee PC. Consequences of Circadian Disruption on Neurologic Health. Sleep Med Clin. 2015 Dec; 10(4):469-80. PMID: 26568123.
    Citations: 17     Fields:    Translation:HumansAnimals
  54. Augustine EF, Pérez A, Dhall R, Umeh CC, Videnovic A, Cambi F, Wills AM, Elm JJ, Zweig RM, Shulman LM, Nance MA, Bainbridge J, Suchowersky O. Sex Differences in Clinical Features of Early, Treated Parkinson's Disease. PLoS One. 2015; 10(7):e0133002. PMID: 26171861.
    Citations: 22     Fields:    Translation:Humans
  55. Simuni T, Caspell-Garcia C, Coffey C, Chahine LM, Lasch S, Oertel WH, Mayer G, Högl B, Postuma R, Videnovic A, Amara AW, Marek K. Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study. Mov Disord. 2015 Sep; 30(10):1371-81. PMID: 26095202.
    Citations: 20     Fields:    Translation:Humans
  56. Videnovic A, Lazar AS, Barker RA, Overeem S. 'The clocks that time us'--circadian rhythms in neurodegenerative disorders. Nat Rev Neurol. 2014 Dec; 10(12):683-93. PMID: 25385339.
    Citations: 104     Fields:    Translation:HumansAnimals
  57. Videnovic A, Breen DP, Barker RA, Zee PC. The central clock in patients with Parkinson disease--reply. JAMA Neurol. 2014 Nov; 71(11):1456-7. PMID: 25383776.
    Citations: 3     Fields:    Translation:Humans
  58. Abbott SM, Videnovic A. Sleep Disorders in Atypical Parkinsonism. Mov Disord Clin Pract. 2014 Jun 01; 1(2):89-96. PMID: 24955381.
    Citations: 14     
  59. Videnovic A, Noble C, Reid KJ, Peng J, Turek FW, Marconi A, Rademaker AW, Simuni T, Zadikoff C, Zee PC. Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA Neurol. 2014 Apr; 71(4):463-9. PMID: 24566763.
    Citations: 83     Fields:    Translation:Humans
  60. Videnovic A, Marlin C, Alibiglou L, Planetta PJ, Vaillancourt DE, Mackinnon CD. Increased REM sleep without atonia in Parkinson disease with freezing of gait. Neurology. 2013 Sep 17; 81(12):1030-5. PMID: 23946301.
    Citations: 13     Fields:    Translation:Humans
  61. Videnovic A. Treatment of huntington disease. Curr Treat Options Neurol. 2013 Aug; 15(4):424-38. PMID: 23417276.
    Citations: 9     
  62. Schenck CH, Montplaisir JY, Frauscher B, Hogl B, Gagnon JF, Postuma R, Sonka K, Jennum P, Partinen M, Arnulf I, Cochen de Cock V, Dauvilliers Y, Luppi PH, Heidbreder A, Mayer G, Sixel-Döring F, Trenkwalder C, Unger M, Young P, Wing YK, Ferini-Strambi L, Ferri R, Plazzi G, Zucconi M, Inoue Y, Iranzo A, Santamaria J, Bassetti C, Möller JC, Boeve BF, Lai YY, Pavlova M, Saper C, Schmidt P, Siegel JM, Singer C, St Louis E, Videnovic A, Oertel W. Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group. Sleep Med. 2013 Aug; 14(8):795-806. PMID: 23886593.
    Citations: 46     Fields:    Translation:Humans
  63. Zee PC, Attarian H, Videnovic A. Circadian rhythm abnormalities. Continuum (Minneap Minn). 2013 Feb; 19(1 Sleep Disorders):132-47. PMID: 23385698.
    Citations: 41     Fields:    Translation:HumansAnimals
  64. Malkani R, Zadikoff C, Melen O, Videnovic A, Borushko E, Simuni T. Amantadine for freezing of gait in patients with Parkinson disease. Clin Neuropharmacol. 2012 Nov-Dec; 35(6):266-8. PMID: 23123688.
    Citations: 10     Fields:    Translation:Humans
  65. Videnovic A, Golombek D. Circadian and sleep disorders in Parkinson's disease. Exp Neurol. 2013 May; 243:45-56. PMID: 22935723.
    Citations: 57     Fields:    Translation:HumansAnimals
  66. Oguh O, Videnovic A. Inpatient management of Parkinson disease: current challenges and future directions. Neurohospitalist. 2012 Jan; 2(1):28-35. PMID: 23983860.
    Citations: 10     
  67. Kuhta T, Zadikoff C, Simuni T, Martel A, Williams K, Videnovic A. Brain donation--what do patients with movement disorders know and how do they feel about it? Parkinsonism Relat Disord. 2011 Mar; 17(3):204-7. PMID: 21220205.
    Citations: 7     Fields:    Translation:Humans
  68. Videnovic A, Comella CL. Sleep disorders in Parkinson's disease. Handb Clin Neurol. 2011; 99:997-1010. PMID: 21056240.
    Citations: 1     Fields:    Translation:Humans
  69. Simuni T, Borushko E, Avram MJ, Miskevics S, Martel A, Zadikoff C, Videnovic A, Weaver FM, Williams K, Surmeier DJ. Tolerability of isradipine in early Parkinson's disease: a pilot dose escalation study. Mov Disord. 2010 Dec 15; 25(16):2863-6. PMID: 20818667.
    Citations: 26     Fields:    Translation:HumansCTClinical Trials
  70. Videnovic A, Bernard B, Fan W, Jaglin J, Leurgans S, Shannon KM. The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease. Mov Disord. 2010 Feb 15; 25(3):401-4. PMID: 20108371.
    Citations: 16     Fields:    Translation:HumansPHPublic Health
  71. Videnovic A, Leurgans S, Fan W, Jaglin J, Shannon KM. Daytime somnolence and nocturnal sleep disturbances in Huntington disease. Parkinsonism Relat Disord. 2009 Jul; 15(6):471-4. PMID: 19041273.
    Citations: 20     Fields:    Translation:Humans
  72. Videnovic A, Metman LV. Deep brain stimulation for Parkinson's disease: prevalence of adverse events and need for standardized reporting. Mov Disord. 2008 Feb 15; 23(3):343-9. PMID: 17987644.
    Citations: 37     Fields:    Translation:Humans
  73. Videnovic A, Semenov I, Chua-Adajar R, Baddi L, Blumenthal DT, Beck AC, Simuni T, Futterer S, Gradishar W, Tellez C, Raizer JJ. Capecitabine-induced multifocal leukoencephalopathy: a report of five cases. Neurology. 2005 Dec 13; 65(11):1792-4; discussion 1685. PMID: 16237130.
    Citations: 8     Fields:    Translation:Humans
  74. Bhangoo S, Chua R, Hammond C, Kimmel Z, Semenov I, Videnovic A, Kessler J, Borsody M. Focal neurological injury caused by West Nile virus infection may occur independent of patient age and premorbid health. J Neurol Sci. 2005 Jul 15; 234(1-2):93-8. PMID: 15958267.
    Citations: 4     Fields:    Translation:HumansCells
  75. Zeidman LA, Videnovic A, Bernstein LP, Pellar CA. Lethal pontine hemorrhage in postpartum syndrome of hemolysis, elevated liver enzyme levels, and low platelet count. Arch Neurol. 2005 Jul; 62(7):1150-3. PMID: 16009775.
    Citations: 5     Fields:    Translation:Humans
  76. Carley DW, Berecek K, Videnovic A, Radulovacki M. Sleep-disordered respiration in phenotypically normotensive, genetically hypertensive rats. Am J Respir Crit Care Med. 2000 Oct; 162(4 Pt 1):1474-9. PMID: 11029364.
    Citations: 9     Fields:    Translation:Animals
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Videnovic's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (174)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.